Vimarsana
Biggest News Aggregation in the World

Page 2 - Jon Koff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jon Koff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jon Koff Today - Breaking & Trending Today

Felix Biotechnology announces initiation of the CYPHY Phase 1/2 study at Yale for its lead asset targeting P. aeruginosa infections - Vimarsana News

Felix Biotechnology announces initiation of the CYPHY Phase 1/2 study at Yale for its lead asset targeting P. aeruginosa infections

Share this article Share this article SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ -- Felix Biotechnology today announced the initiation of CYPHY, a Phase 1/2 investigator-initiated single center trial at Yale University for targeted phage therapy YPT-01 in the treatment of chronic P. aeruginosa infections in cystic fibrosis. This double-blind, placebo-controlled study ( NCT 04684641) will assess the safety and efficacy of YPT-01 added to standard antimicrobial therapy  in 36 patients. CYPHY will also assess the ability of YPT-01 to reduce the virulence and antibiotic-resistance of P. aerugi...